北爱尔兰开始推出每月或双月一次的艾滋病毒预防注射(cabotegravir), Northern Ireland begins rolling out monthly or bimonthly HIV prevention injection, cabotegravir, following NICE guidance.

一项长期艾滋病毒预防注射,即卡博特格拉维(CAB-LA),正在北爱尔兰推出,这是根据全国儿童教育协会的指导,每月或每两个月提供一次替代每日口服PREP的替代药物。 A long-acting HIV prevention injection, cabotegravir (CAB-LA), is being rolled out in Northern Ireland, following NICE guidance, offering a monthly or bimonthly alternative to daily oral PrEP. 此举得到了卫生官员的认可，并被彩虹项目等倡导组织誉为“游戏规则改变者”，旨在改善那些因耻辱感、生活方式或依从性挑战而与日常服药作斗争的人的机会。 The move, endorsed by health officials and hailed as a "game-changer" by advocacy groups like The Rainbow Project, aims to improve access for those struggling with daily pills due to stigma, lifestyle, or adherence challenges. 它支持联合王国到2030年结束艾滋病毒新传播的目标,尽管尚未推出细节,公共教育和服务准入等障碍依然存在。 It supports the UK’s goal of ending new HIV transmissions by 2030, though rollout details remain pending and barriers like public education and service access persist.